Health Canada’s personal importation policy and associated guidance can be found in the following two documents POL 060 and GUI 084. Once a product is legally brought into Canada under this policy, the administration of it would be overseen by practice of medicine provisions. There are no federal limitations on who administers the medication, including self administration or administration by a healthcare professional. Specifically, with respect to edaravone, there are no federal barriers to the administration of the medication by a nurse.
We’ve had some issues when people see wording that says that edaravone is “not approved for use” in Canada. It is true, as you know, that it hasn’t been submitted, reviewed and granted market authorization, but importation of a 90 day supply under the personal importation policy is a legal mechanism for access. Just raising it, because some healthcare professionals have read similar wording and interpreted it as indicating that the administration of edaravone obtained under this mechanism is in some way not appropriate.
NOTE: Edaravone (which is made by Kyorin) is the generic version of Radicava/ Radicut (which is made by MTPharma). Dr Hiide Yoshino supplies edaravone because radicava is more than 2 times as expensive.
Copyright ©Right To Try Act Canada. All rights reserved.